PE20191105A1 - Inhibidores de moleculas pequenas de lafamilia de quinasas jak - Google Patents
Inhibidores de moleculas pequenas de lafamilia de quinasas jakInfo
- Publication number
- PE20191105A1 PE20191105A1 PE2019001252A PE2019001252A PE20191105A1 PE 20191105 A1 PE20191105 A1 PE 20191105A1 PE 2019001252 A PE2019001252 A PE 2019001252A PE 2019001252 A PE2019001252 A PE 2019001252A PE 20191105 A1 PE20191105 A1 PE 20191105A1
- Authority
- PE
- Peru
- Prior art keywords
- inhibitors
- kinas
- jak
- family
- small molecules
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 150000003384 small molecules Chemical class 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 229940122245 Janus kinase inhibitor Drugs 0.000 abstract 1
- 150000007960 acetonitrile Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Referido a compuestos de 2-((1r,4r)-4-(imidazo[4,5-d]pirrolo[2,3-b]piridina-1(6H)-il)ciclohexil)acetonitrilo, inhibidores de las quinasas Janus (Jack). Ademas, se refiere a composiciones farmaceuticas, metodos de elaboracion, y su uso en el tratamiento de enfermedades, trastornos y condiciones mediadas por Jack.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662435609P | 2016-12-16 | 2016-12-16 | |
| US201762592680P | 2017-11-30 | 2017-11-30 | |
| US201762596607P | 2017-12-08 | 2017-12-08 | |
| PCT/US2017/066744 WO2018112379A1 (en) | 2016-12-16 | 2017-12-15 | Small molecule inhibitors of the jak family of kinases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20191105A1 true PE20191105A1 (es) | 2019-08-23 |
Family
ID=61692222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2019001252A PE20191105A1 (es) | 2016-12-16 | 2017-12-15 | Inhibidores de moleculas pequenas de lafamilia de quinasas jak |
Country Status (35)
| Country | Link |
|---|---|
| US (5) | US10294226B2 (es) |
| EP (2) | EP4086256A1 (es) |
| JP (2) | JP7291077B2 (es) |
| KR (1) | KR102352462B1 (es) |
| CN (1) | CN110088105B (es) |
| AU (3) | AU2017377069B2 (es) |
| CL (1) | CL2019001626A1 (es) |
| CO (1) | CO2019006200A2 (es) |
| CR (1) | CR20190282A (es) |
| CY (1) | CY1125460T1 (es) |
| DK (1) | DK3555097T3 (es) |
| EC (1) | ECSP19042688A (es) |
| ES (1) | ES2922379T3 (es) |
| HR (1) | HRP20220885T1 (es) |
| HU (1) | HUE059274T2 (es) |
| IL (1) | IL267275B (es) |
| JO (1) | JOP20190143B1 (es) |
| LT (1) | LT3555097T (es) |
| MD (1) | MD3555097T2 (es) |
| MX (2) | MX2022004474A (es) |
| MY (1) | MY196260A (es) |
| NI (1) | NI201900060A (es) |
| NZ (1) | NZ795615A (es) |
| PE (1) | PE20191105A1 (es) |
| PH (1) | PH12019501254A1 (es) |
| PL (1) | PL3555097T3 (es) |
| PT (1) | PT3555097T (es) |
| RS (1) | RS63500B1 (es) |
| SA (1) | SA519402216B1 (es) |
| SI (1) | SI3555097T1 (es) |
| SM (1) | SMT202200326T1 (es) |
| TW (1) | TWI777997B (es) |
| UA (1) | UA125042C2 (es) |
| WO (1) | WO2018112379A1 (es) |
| ZA (1) | ZA201904615B (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3640251T3 (pl) | 2016-10-24 | 2022-04-11 | Astrazeneca Ab | Pochodne 6,7,8,9-tetrahydro-3H-pirazolo[4,3-f]izochinoliny przydatne w leczeniu nowotworu złośliwego |
| PE20191105A1 (es) | 2016-12-16 | 2019-08-23 | Janssen Pharmaceutica Nv | Inhibidores de moleculas pequenas de lafamilia de quinasas jak |
| TWI831738B (zh) | 2016-12-16 | 2024-02-11 | 美商瑞塔醫藥有限責任公司 | 用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物 |
| JOP20190144A1 (ar) * | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
| MY196317A (en) | 2017-01-30 | 2023-03-24 | Astrazeneca Ab | Estrogen Receptor Modulators |
| TW202016110A (zh) | 2018-06-15 | 2020-05-01 | 比利時商健生藥品公司 | Ｊａｋ激酶家族之小分子抑制劑 |
| CA3103726A1 (en) | 2018-06-15 | 2019-12-19 | Reata Pharmaceuticals, Inc. | Pyrazole and imidazole compounds for inhibition of il-17 and rorgamma |
| EP3810141A1 (en) | 2018-06-20 | 2021-04-28 | Reata Pharmaceuticals, Inc. | Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith |
| WO2020216936A1 (en) | 2019-04-24 | 2020-10-29 | Janssen Pharmaceutica Nv | Non-clinical liquid formulations of pan-jak inhibitor |
| IL319797A (en) | 2019-06-06 | 2025-05-01 | Hangzhou Highlightll Pharmaceutical Co Ltd | Method for synthesizing a furoimidazopyridine compound, a crystalline form of a furoimidazopyridine compound, and a crystalline form of a salt thereof |
| CN110483514B (zh) | 2019-09-16 | 2022-06-14 | 启元生物(杭州)有限公司 | 一种氰基取代的环肼衍生物及其应用 |
| WO2021062163A1 (en) | 2019-09-27 | 2021-04-01 | Disc Medicine, Inc. | Methods for treating myelofibrosis and related conditions |
| ES3037893T3 (en) | 2020-02-21 | 2025-10-07 | Zhuhai United Laboratories Co Ltd | Crystalline form of jak inhibitor and application thereof |
| IL297218A (en) | 2020-04-24 | 2022-12-01 | Astrazeneca Ab | Pharmaceutical formulations |
| WO2021214253A1 (en) | 2020-04-24 | 2021-10-28 | Astrazeneca Ab | Dosage regimen for the treatment of cancer |
| CA3177830A1 (en) | 2020-05-13 | 2021-11-18 | Maria BECONI | Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis |
| CN114149428B (zh) * | 2020-09-08 | 2023-06-13 | 中国药科大学 | 吡啶并环类化合物及其制备方法、中间体、组合物和应用 |
| EP4304590A1 (en) | 2021-03-11 | 2024-01-17 | Janssen Pharmaceutica NV | Lorpucitinib for use in the treatment of jak mediated disorders |
| CN113292561A (zh) * | 2021-05-22 | 2021-08-24 | 中国药科大学 | 一种二吡咯并吡啶结构的化合物、制备方法和医药用途 |
| CN114432317A (zh) * | 2021-05-31 | 2022-05-06 | 广州嘉越医药科技有限公司 | 吡咯并嘧啶类化合物的用途 |
| CN113861194B (zh) * | 2021-11-10 | 2022-07-05 | 英维沃化工科技(广州)有限公司 | 一种含吡咯并吡啶双酰胺咪唑类化合物及其制备方法和应用 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080747A (en) | 1999-03-05 | 2000-06-27 | Hughes Institute | JAK-3 inhibitors for treating allergic disorders |
| YU75301A (sh) | 1999-04-23 | 2004-07-15 | Smithkline Beecham P.L.C. | Polimorfni oblik soli maleinske kiseline i 5-(4-(2-(n-metil- n-(2-piridil)amino)etoksi)benzil)-tiazolidin-2,4-diona |
| AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
| WO2003101991A1 (en) | 2002-05-31 | 2003-12-11 | Schering Corporation | Xanthine phosphodiesterase v inhibitor polymorphs |
| GB0319935D0 (en) | 2003-08-26 | 2003-09-24 | Cipla Ltd | Polymorphs |
| US7737279B2 (en) | 2005-05-10 | 2010-06-15 | Bristol-Myers Squibb Company | 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same |
| WO2007005462A1 (en) | 2005-07-01 | 2007-01-11 | Wyeth | Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarb-onitrile and methods of preparing the same |
| EP2251341A1 (en) * | 2005-07-14 | 2010-11-17 | Astellas Pharma Inc. | Heterocyclic Janus kinase 3 inhibitors |
| US8163767B2 (en) | 2005-07-14 | 2012-04-24 | Astellas Pharma Inc. | Heterocyclic Janus Kinase 3 inhibitors |
| UY31881A (es) | 2008-06-10 | 2010-01-29 | Abbott Lab | Derivados sustituidos de imidazo[1,5-a]pirrolo[2,3-e]pirazinas e imidazo[1,2-a]pirrolo[2,3-e]pirazinas, sus sales, prodrogas, metabolitos biológicalmente activos, estereoisómeros e isómeros farmacéuticamente aceptables. |
| CA2772616C (en) | 2009-09-03 | 2017-09-19 | Bristol-Myers Squibb Company | Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer |
| JP2011066747A (ja) * | 2009-09-18 | 2011-03-31 | Panasonic Corp | 弾性波フィルタ |
| NZ600161A (en) | 2009-12-01 | 2014-08-29 | Abbvie Inc | Novel tricyclic compounds |
| MX2012006381A (es) | 2009-12-01 | 2012-06-19 | Abbott Lab | Nuevos compuestos triciclicos. |
| WO2011086053A1 (en) * | 2010-01-12 | 2011-07-21 | F. Hoffmann-La Roche Ag | Tricyclic heterocyclic compounds, compositions and methods of use thereof |
| AU2011214254B2 (en) | 2010-02-10 | 2016-06-09 | Genon Biotechnologies Oy | Dual activity kinase domains and uses thereof |
| WO2013007765A1 (en) | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Fused tricyclic compounds for use as inhibitors of janus kinases |
| GB201212081D0 (en) | 2012-07-06 | 2012-08-22 | Kalvista Pharmaceuticals Ltd | New polymorph |
| US9475813B2 (en) | 2013-02-08 | 2016-10-25 | Nissan Chemical Industries, Ltd. | Tricyclic pyrrolopyridine compound, and JAK inhibitor |
| EP2924026A1 (en) * | 2014-03-28 | 2015-09-30 | Novartis Tiergesundheit AG | Aminosulfonylmethylcyclohexanes as JAK inhibitors |
| MX374105B (es) | 2014-05-14 | 2025-03-05 | Nissan Chemical Ind Ltd | Compuestos azatricíclicos como inhibidores de tirosinas quinasas (jak) y el uso de los mismos en el tratamiento de enfermedades autoinmunes, inflamatorias y alérgicas. |
| MX378963B (es) | 2015-05-28 | 2025-03-10 | Theravance Biopharma R&D Ip Llc | Compuestos de naftiridina como inhibidores de quinasa jak. |
| EP3371332A4 (en) | 2015-11-04 | 2019-04-03 | Mayo Foundation for Medical Education and Research | METHOD AND MATERIALS FOR TREATING AUTOIMMUNE DISEASES |
| JOP20190053A1 (ar) | 2016-09-23 | 2019-03-21 | Novartis Ag | مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط |
| PL3640251T3 (pl) | 2016-10-24 | 2022-04-11 | Astrazeneca Ab | Pochodne 6,7,8,9-tetrahydro-3H-pirazolo[4,3-f]izochinoliny przydatne w leczeniu nowotworu złośliwego |
| RU2019121534A (ru) | 2016-12-16 | 2021-01-18 | Басф Се | Пестицидные соединения |
| EA037318B1 (ru) | 2016-12-16 | 2021-03-11 | Пфайзер Инк. | Агонисты рецептора glp-1 и их применение |
| JOP20190144A1 (ar) | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
| PE20191105A1 (es) | 2016-12-16 | 2019-08-23 | Janssen Pharmaceutica Nv | Inhibidores de moleculas pequenas de lafamilia de quinasas jak |
| US20190281874A1 (en) | 2016-12-16 | 2019-09-19 | Nestec S.A. | Oligosaccharides for flavour generation |
| EA036112B1 (ru) | 2016-12-16 | 2020-09-29 | Эли Лилли Энд Компани | 7-фенилэтиламино-4h-пиримидо[4,5-d][1,3]оксазин-2-оновые соединения в качестве ингибиторов мутантных idh1 и idh2 |
| US10703751B2 (en) | 2017-01-11 | 2020-07-07 | Leo Pharma A/S | Amino-imidazopyridine derivatives as Janus kinase inhibitors and pharmaceutical use thereof |
| MY196317A (en) | 2017-01-30 | 2023-03-24 | Astrazeneca Ab | Estrogen Receptor Modulators |
| TWI778050B (zh) | 2017-04-21 | 2022-09-21 | 美商醫肯納腫瘤學公司 | 吲哚ahr抑制劑及其用途 |
| CN106881892B (zh) | 2017-04-27 | 2020-10-16 | 双钱集团（江苏）轮胎有限公司 | 一种轮胎生产用生胎转移系统 |
| TW202016110A (zh) | 2018-06-15 | 2020-05-01 | 比利時商健生藥品公司 | Ｊａｋ激酶家族之小分子抑制劑 |
| WO2020216936A1 (en) | 2019-04-24 | 2020-10-29 | Janssen Pharmaceutica Nv | Non-clinical liquid formulations of pan-jak inhibitor |
-
2017
- 2017-12-15 PE PE2019001252A patent/PE20191105A1/es unknown
- 2017-12-15 KR KR1020197020121A patent/KR102352462B1/ko active Active
- 2017-12-15 HU HUE17854175A patent/HUE059274T2/hu unknown
- 2017-12-15 PT PT178541751T patent/PT3555097T/pt unknown
- 2017-12-15 MD MDE20191212T patent/MD3555097T2/ro unknown
- 2017-12-15 CR CR20190282A patent/CR20190282A/es unknown
- 2017-12-15 JP JP2019531668A patent/JP7291077B2/ja active Active
- 2017-12-15 EP EP22178880.5A patent/EP4086256A1/en active Pending
- 2017-12-15 WO PCT/US2017/066744 patent/WO2018112379A1/en not_active Ceased
- 2017-12-15 US US15/843,642 patent/US10294226B2/en active Active
- 2017-12-15 MY MYPI2019003389A patent/MY196260A/en unknown
- 2017-12-15 NZ NZ795615A patent/NZ795615A/en unknown
- 2017-12-15 AU AU2017377069A patent/AU2017377069B2/en active Active
- 2017-12-15 SM SM20220326T patent/SMT202200326T1/it unknown
- 2017-12-15 HR HRP20220885TT patent/HRP20220885T1/hr unknown
- 2017-12-15 UA UAA201908086A patent/UA125042C2/uk unknown
- 2017-12-15 PL PL17854175.1T patent/PL3555097T3/pl unknown
- 2017-12-15 TW TW106144095A patent/TWI777997B/zh active
- 2017-12-15 DK DK17854175.1T patent/DK3555097T3/da active
- 2017-12-15 JO JOP/2019/0143A patent/JOP20190143B1/ar active
- 2017-12-15 LT LTEPPCT/US2017/066744T patent/LT3555097T/lt unknown
- 2017-12-15 SI SI201731186T patent/SI3555097T1/sl unknown
- 2017-12-15 ES ES17854175T patent/ES2922379T3/es active Active
- 2017-12-15 RS RS20220753A patent/RS63500B1/sr unknown
- 2017-12-15 MX MX2022004474A patent/MX2022004474A/es unknown
- 2017-12-15 EP EP17854175.1A patent/EP3555097B1/en active Active
- 2017-12-15 CN CN201780077753.4A patent/CN110088105B/zh active Active
- 2017-12-15 MX MX2019007073A patent/MX391936B/es unknown
-
2019
- 2019-01-09 US US16/243,874 patent/US10364246B2/en active Active
- 2019-02-12 US US16/274,142 patent/US11059823B2/en active Active
- 2019-02-13 US US16/275,045 patent/US10487083B2/en active Active
- 2019-06-06 PH PH12019501254A patent/PH12019501254A1/en unknown
- 2019-06-12 IL IL267275A patent/IL267275B/en unknown
- 2019-06-12 CL CL2019001626A patent/CL2019001626A1/es unknown
- 2019-06-13 SA SA519402216A patent/SA519402216B1/ar unknown
- 2019-06-14 CO CONC2019/0006200A patent/CO2019006200A2/es unknown
- 2019-06-14 NI NI201900060A patent/NI201900060A/es unknown
- 2019-06-14 EC ECSENADI201942688A patent/ECSP19042688A/es unknown
- 2019-07-15 ZA ZA2019/04615A patent/ZA201904615B/en unknown
-
2020
- 2020-10-21 AU AU2020257068A patent/AU2020257068A1/en not_active Abandoned
-
2021
- 2021-06-23 US US17/355,472 patent/US12202831B2/en active Active
-
2022
- 2022-06-17 AU AU2022204240A patent/AU2022204240B2/en active Active
- 2022-08-02 CY CY20221100530T patent/CY1125460T1/el unknown
-
2023
- 2023-02-13 JP JP2023019626A patent/JP7493068B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20191105A1 (es) | Inhibidores de moleculas pequenas de lafamilia de quinasas jak | |
| PH12019501355A1 (en) | Small molecule inhibitors of the jak family of kinases | |
| EA201790995A1 (ru) | ЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ И ИХ ПРИМЕНЕНИЕ ПРИ ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ | |
| EA201991109A1 (ru) | ПРОИЗВОДНЫЕ [1,2,4]ТРИАЗОЛО[1,5-a]ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PDE2 | |
| EA201891067A1 (ru) | [1,2,4]ТРИАЗОЛО[1,5-a]ПИРИМИДИН-7-ИЛЬНОЕ СОЕДИНЕНИЕ | |
| NI202000100A (es) | Inhibidores de moléculas pequeñas de la familia de quinasa jak | |
| EA201891897A1 (ru) | 1,5-ДИГИДРО-4H-ПИРАЗОЛО[3,4-d]ПИРИМИДИН-4-ОНЫ И 1,5-ДИГИДРО-4H-ПИРАЗОЛО[4,3-c]ПИРИДИН-4-ОНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ PDE1 | |
| EA201991094A1 (ru) | СОЕДИНЕНИЯ [1,2,4]ТРИАЗОЛО[1,5-a]ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PDE2 | |
| IL246034B (en) | History of [1,2,4]triazolo[1,5-a]pyrimidine as protozoan proteasome inhibitors for the treatment of parasitic diseases such as Jericho | |
| EA201990973A1 (ru) | СОЕДИНЕНИЯ [1,2,4]ТРИАЗОЛО[1,5-a]ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PDE2 | |
| TH1901003656A (th) | สารยับยั้งที่มีโมเลกุลขนาดเล็กของวงศ์ jak ของไคเนส | |
| EA201991473A1 (ru) | Имидазопирролопиридин в качестве ингибиторов киназ семейства jak | |
| EA201991472A1 (ru) | Низкомолекулярные ингибиторы киназ семейства jak | |
| EA202190047A1 (ru) | Низкомолекулярные ингибиторы киназ семейства jak | |
| AR114969A1 (es) | Inhibidores de moléculas pequeñas de la familia de quinasas jak |